Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 84-89

  Vogiatzi, Konstantina ^a   Voudris, Vassilis ^b   Apostolakis, Stavros ^a   Kochiadakis, Georgios E ^c   Thomopoulou, Sofia ^b   Zaravinos, Apostolos ^a   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

coronary artery disease; DNA sequencing; in stent restenosis; polymorphism; RANTES

Indexed keywords

RANTES;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EVALUATION; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROMOTER REGION; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

AGED; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL5; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE SUSCEPTIBILITY; DNA; FEMALE; GENETIC VARIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 64949160837     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.12.043     Document Type: Article

References (20)

1. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
2. Reape T.J., and Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 147 (1999) 213-225
3. Apostolakis S., Papadakis E.G., Krambovitis E., and Spandidos D.A. Chemokines in vascular pathology. Int J Mol Med 17 (2006) 691-701
4. Pattison J.M., Nelson P.J., Huie P., Sibley R.K., and Krensky A.M. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 15 (1996) 1194-1199
5. Song A., Nikolcheva T., and Krensky A.M. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev 177 (2000) 236-245
6. Wilcox J.N., Nelken N.A., Coughlin S.R., Gordon D., and Schall T.J. Local expression of inflammatory cytokines in human atherosclerotic plaques. J Arterioscler Thromb 1 Suppl (1994) S3-S10
7. Pattison J.M., Nelson P.J., Huie P., Sibley R.K., and Krensky A.M. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 15 (1996) 1194-1199
8. Fryer A.A., Spiteri M.A., Bianco A., Hepple M., Jones P.W., Strange R.C., et al. The - 403 G/A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 1 (2000) 509-514
9. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Ikeda F., Kanno R., et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 26 (2003) 892-898
10. Liu H., Chao D., Nakayama E.E., Taguchi H., Goto M., Xin X., et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96 (1999) 4581-4585
11. Nickel R.G., Casolaro V., Wahn U., Beyer K., Barnes K.C., Plunkett B.S., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164 (2000) 1612-1616
12. McDermott D.H., Beecroft M.J., Kleeberger C.A., Al-Sharif F.M., Ollier W.E., Zimmerman P.A., et al. Chemokine RANTES promoter polymorphisms affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. Aids 14 (2000) 2671-2678
13. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10 (2003) 1-78
14. Amanatidou V., Sourvinos G., Apostolakis S., Neonaki P., Tsilimigaki A., Krambovitis E., et al. RANTES Promoter Gene Polymorphisms and Susceptibility to Severe Respiratory Syncytial Virus-Induced Bronchiolitis. Pediatr Infect Dis J 27 (2007) 38-42
15. Veillard N.R., Kwak B., Pelli G., Mulhaupt F., James R.W., Proudfoot A.E., et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94 (2004) 253-261
16. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 - 2518 G/G genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
17. Gonzalez P., Alvarez R., Batalla A., Reguero J.R., Alvarez V., Astudillo A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2 (2001) 191-195
18. Apostolakis S., Baritaki S., Kochiadakis G.E., Igoumenidis N.E., Panutsopulos D., and Spandidos D.A. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res 119 (2007) 63-71
19. Boger C.A., Fischereder M., Deinzer M., Aslanidis C., Schmitz G., Stubanus M., et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 183 (2005) 121-129
20. Simeoni E., Winkelmannc B.R., Hoffmannd M.M., Fleurya S., Ruize J., Kappenbergera L., et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25 (2004) 1438-1446